TrialThe Journal of clinical endocrinology and metabolism2020

Maintenance of Acromegaly Control in Patients Switching From Injectable Somatostatin Receptor Ligands to Oral Octreotide.

Susan L Samson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.